What’s Next? Five Things To Look Out For In June

Formycon Awaits FDA Aflibercept Date; Chinese Patent For Roxadustat Reaches End

 
• By Dean Rudge
  
What's Next Image
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products